Acute Pancreatitis Secondary to Pembrolizumab-Induced Hypertriglyceridemia

Pembrolizumab is a humanized monoclonal antibody targeted against programmed cell death protein 1 (PD-1) receptor of lymphocytes. It is used alone or in combination with many chemotherapy regimens for a wide variety of cancers. It has been reported to cause various side effects including endocrinopa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashfaq, Ammar, Thalambedu, Nishanth, Atiq, Muhammad Umair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227188/
https://www.ncbi.nlm.nih.gov/pubmed/37261185
http://dx.doi.org/10.7759/cureus.38315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227188/
https://www.ncbi.nlm.nih.gov/pubmed/37261185
http://dx.doi.org/10.7759/cureus.38315

Ejemplares similares